GlassScriptPhysician profile
Dori L Hunt
NPI 1770585788
$2,172.81
in general payments reported to CMS, 2019-2025
20 companies · $312 in 2025
The $312 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $91.90 · 2021: $291 · 2022: $116 · 2023: $520 · 2024: $492 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $945 · Education: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $945.47 |
| Education | $377.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $736.64 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $360.02 | 2022-2025 | Ilumya |
| Janssen Biotech, INC. | $187.39 | 2019-2025 | Tremfya |
| Pfizer INC. | $138.26 | 2019-2024 | |
| Ucb, INC. | $129.43 | 2019-2025 | Bimzelx |
| Medimetriks Pharmaceuticals, INC. | $119.94 | 2019-2023 | |
| Strata Skin Sciences, INC. | $102.19 | 2021-2025 | Xtrac |
| Novartis Pharmaceuticals Corporation | $65.91 | 2019 | |
| Galderma Laboratories, L.P. | $59.85 | 2024-2025 | Nemluvio, Aklief |
| Mentor Worldwide LLC | $40.68 | 2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Medline Industries LP | $38.44 | 2023 | |
| Organogenesis INC. | $36.94 | 2023-2024 | Puraply, Apligraf |
| Allergan, INC. | $32.67 | 2019-2020 | |
| Leo Pharma INC. | $26.96 | 2024 | Adbry |
| Journey Medical Corporation | $23.57 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $16.32 | 2024 | Erivedge |
| Mayne Pharma Commercial LLC | $15.54 | 2019 | |
| Dermavant Sciences, INC. | $15.11 | 2023 | Vtama |
| Dusa Pharmaceuticals, INC. | $13.61 | 2019 | |
| Vyne Pharmaceuticals INC. | $13.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dori Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.